Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

15.3K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
15.3K
Cancer Survival Analysis01:21

Cancer Survival Analysis

645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

238
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
238
Probability Laws01:49

Probability Laws

43.9K
Overview
43.9K
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

889
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
889
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

1.0K
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
1.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

BiGER: Bayesian rank aggregation in genomics with extended ranking schemes.

Nature communicationsĀ·2026
Same author

Large-Scale Evaluation of Traditional Chinese Medicines Reveals Potential PPARγ Modulators for Type 2 Diabetes Management.

Journal of clinical laboratory analysisĀ·2026
Same author

MisTIC: Missegmented Transcript Inference Correction for Improved Spatial Transcriptomics Analysis.

bioRxiv : the preprint server for biologyĀ·2025
Same author

Mapping cellular interactions from spatially resolved transcriptomics data.

Nature methodsĀ·2024
Same author

Assessing next-generation sequencing-based computational methods for predicting transcriptional regulators with query gene sets.

Briefings in bioinformaticsĀ·2024
Same author

BIT: Bayesian Identification of Transcriptional Regulators from Epigenomics-Based Query Region Sets.

bioRxiv : the preprint server for biologyĀ·2024

Related Experiment Video

Updated: Jan 13, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K

A Bayesian Model for Paired Data in Genome-Wide Association Studies with Application to Breast Cancer.

Yashi Bu1, Min Chen1, Zhenyu Xuan2

  • 1Department of Mathematical Sciences, University of Texas at Dallas, Richardson, TX 75080, USA.

Entropy (Basel, Switzerland)
|October 28, 2025
PubMed
Summary

This study expands genome-wide association studies (GWASs) for cancer by analyzing tumor and normal tissues to detect somatic mutations. New methods improve the identification of genetic variants linked to complex diseases.

Keywords:
TCGAsingle nucleotide polymorphismsomatic mutation

More Related Videos

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.6K

Related Experiment Videos

Last Updated: Jan 13, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
12:39

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types

Published on: December 10, 2012

11.7K
Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases
07:41

Performing Data Mining And Integrative Analysis Of Biomarker in Breast Cancer Using Multiple Publicly Accessible Databases

Published on: May 17, 2019

9.4K
gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair
08:15

gDNA Enrichment by a Transposase-based Technology for NGS Analysis of the Whole Sequence of BRCA1, BRCA2, and 9 Genes Involved in DNA Damage Repair

Published on: October 6, 2014

12.6K

Area of Science:

  • Genetics
  • Oncology
  • Bioinformatics

Background:

  • Complex human diseases, such as cancer, have strong genetic components.
  • Genome-wide association studies (GWASs) are key for identifying genetic variants associated with cancer.
  • Current GWAS methods primarily use case-control data, limiting their scope.

Purpose of the Study:

  • To propose novel approaches for expanding GWAS by utilizing tumor and paired normal tissues.
  • To investigate the role of somatic mutations in complex diseases.
  • To enhance the detection of moderate-effect single nucleotide polymorphisms (SNPs).

Main Methods:

  • Application of penalized maximum likelihood estimation for single-marker analysis.
  • Development of a Bayesian hierarchical model for integrating multiple markers.
  • Identification of SNP sets grouped by genes or biological pathways.

Main Results:

  • Both single- and multiple-marker analyses successfully identified genes associated with breast cancer using The Cancer Genome Atlas (TCGA) data.
  • Multiple-marker analysis demonstrated greater consistency with external genomic resources.
  • The developed Bayesian model significantly improved the potential for novel genetic discoveries.

Conclusions:

  • The proposed methods effectively expand GWAS capabilities by incorporating tumor and normal tissue data to identify somatic mutations.
  • Bayesian hierarchical modeling offers a powerful approach for integrating multi-marker data, enhancing the discovery of genetic associations in complex diseases.
  • This research provides a more robust framework for genetic studies in oncology and other complex diseases.